Yongqiang Wang

Person

Shanghai, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 12,077,571
- Issue date Sep 3, 2024
- Novartis AG
- Johanna Abend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 11,639,378
- Issue date May 2, 2023
- Novartis AG
- Johanna Abend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 11,591,404
- Issue date Feb 28, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for ex...
- Patent number 11,459,390
- Issue date Oct 4, 2022
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-LAG-3 antibodies and uses thereof
- Patent number 11,414,485
- Issue date Aug 16, 2022
- I-MAB BIOPHARMA (HANGZHOU) CO., LTD.
- Lei Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PD-L1 antibodies and uses thereof
- Patent number 11,220,546
- Issue date Jan 11, 2022
- I-MAB BIOPHARMA US LIMITED
- Lei Fang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 11,161,894
- Issue date Nov 2, 2021
- Novartis AG
- Johanna Abend
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-BCMA chimeric antigen receptor
- Patent number 11,084,880
- Issue date Aug 10, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 10,703,819
- Issue date Jul 7, 2020
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 10,654,914
- Issue date May 19, 2020
- Novartis AG
- Johanna Abend
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-LAG-3 antibodies and uses thereof
- Patent number 10,577,421
- Issue date Mar 3, 2020
- I-MAB
- Lei Fang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 10,450,366
- Issue date Oct 22, 2019
- Novartis AG
- Johanna Abend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 10,435,460
- Issue date Oct 8, 2019
- Novartis AG
- Johanna Abend
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
- Patent number 10,174,095
- Issue date Jan 8, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 9,862,760
- Issue date Jan 9, 2018
- Novartis AG
- Johanna Abend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 9,815,901
- Issue date Nov 14, 2017
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SPECIFIC BINDING PROTEIN TARGETING PD-L1 AND CD73
- Publication number 20240269276
- Publication date Aug 15, 2024
- Harbour BioMed (Shanghai) Co., Ltd
- Qianqian Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CCR8 ANTIBODY AND APPLICATION THEREOF
- Publication number 20240228635
- Publication date Jul 11, 2024
- B7 THERAPEUTICS INC.
- Shuang LU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR8 ANTIBODY AND APPLICATION THEREOF
- Publication number 20240132603
- Publication date Apr 25, 2024
- HARBOUR BIOMED US, INC.
- Shuang LU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 ANTIGEN-BINDING PROTEIN AND USE THEREOF
- Publication number 20240034792
- Publication date Feb 1, 2024
- Harbour BioMed (Shanghai) Co., Ltd
- Haishan LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ROR1-TARGETING ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, PREPAR...
- Publication number 20240010721
- Publication date Jan 11, 2024
- Harbour BioMed (Shanghai) Co., Ltd
- Zheng WANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20230399382
- Publication date Dec 14, 2023
- Novartis AG
- Johanna ABEND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING PROTEIN HAVING H2L2 AND HCAB STRUCTURES
- Publication number 20230322953
- Publication date Oct 12, 2023
- Harbour BioMed (Shanghai) Co., Ltd
- Yun HE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-B7H4 ANTIBODY, AND BISPECIFIC ANTIBODY AND USE THEREOF
- Publication number 20230312722
- Publication date Oct 5, 2023
- NONA BIOSCIENCES (SUZHOU) CO., LTD.
- Xiaodong WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230220090
- Publication date Jul 13, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF
- Publication number 20230134183
- Publication date May 4, 2023
- Harbour BioMed (Shanghai) Co., Ltd
- MING-JIN JHENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...
- Publication number 20230052970
- Publication date Feb 16, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Polyomavirus Neutralizing Antibodies
- Publication number 20220363735
- Publication date Nov 17, 2022
- Novartis AG
- Johanna ABEND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-L1 ANTIBODIES AND USES THEREOF
- Publication number 20220119531
- Publication date Apr 21, 2022
- I-MAB Biopharma US Limited
- Lei Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20220064316
- Publication date Mar 3, 2022
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210002377
- Publication date Jan 7, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20200190167
- Publication date Jun 18, 2020
- Novartis AG
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-L1 ANTIBODIES AND USES THEREOF
- Publication number 20200157222
- Publication date May 21, 2020
- l-MAB
- Lei Fang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-LAG-3 ANTIBODIES AND USES THEREOF
- Publication number 20200071403
- Publication date Mar 5, 2020
- I-MAB Biopharma US Limited
- Lei Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED CK AND CH1 DOMAINS
- Publication number 20190389972
- Publication date Dec 26, 2019
- Yongqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-LAG-3 ANTIBODIES AND USES THEREOF
- Publication number 20190225687
- Publication date Jul 25, 2019
- I-MAB
- Lei Fang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...
- Publication number 20190153061
- Publication date May 23, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20190071488
- Publication date Mar 7, 2019
- Novartis AG
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20190002533
- Publication date Jan 3, 2019
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180312595
- Publication date Nov 1, 2018
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...
- Publication number 20180118834
- Publication date May 3, 2018
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20180079799
- Publication date Mar 22, 2018
- Novartis AG
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20170088605
- Publication date Mar 30, 2017
- Novartis AG
- Johanna ABEND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160068601
- Publication date Mar 10, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20160046724
- Publication date Feb 18, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Yongqiang Wang

Person

Patents Grantslast 30 patents

Polyomavirus neutralizing antibodies

Polyomavirus neutralizing antibodies

Treatment of cancer using a CD123 chimeric antigen receptor

Phosphoglycerate kinase 1 (PGK) promoters and methods of use for ex...

Anti-LAG-3 antibodies and uses thereof

Anti-PD-L1 antibodies and uses thereof

Polyomavirus neutralizing antibodies

Anti-BCMA chimeric antigen receptor

Treatment of cancer using a CD123 chimeric antigen receptor

Polyomavirus neutralizing antibodies

Anti-LAG-3 antibodies and uses thereof

Polyomavirus neutralizing antibodies

Polyomavirus neutralizing antibodies

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

Polyomavirus neutralizing antibodies

Treatment of cancer using a CD123 chimeric antigen receptor

Patents Applicationslast 30 patents

SPECIFIC BINDING PROTEIN TARGETING PD-L1 AND CD73

CCR8 ANTIBODY AND APPLICATION THEREOF

CCR8 ANTIBODY AND APPLICATION THEREOF

PD-1 ANTIGEN-BINDING PROTEIN AND USE THEREOF

ROR1-TARGETING ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, PREPAR...

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

BINDING PROTEIN HAVING H2L2 AND HCAB STRUCTURES

ANTI-B7H4 ANTIBODY, AND BISPECIFIC ANTIBODY AND USE THEREOF

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...

Polyomavirus Neutralizing Antibodies

ANTI-PD-L1 ANTIBODIES AND USES THEREOF

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

ANTI-PD-L1 ANTIBODIES AND USES THEREOF

ANTI-LAG-3 ANTIBODIES AND USES THEREOF

MODIFIED CK AND CH1 DOMAINS

ANTI-LAG-3 ANTIBODIES AND USES THEREOF

TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...